Webinars

In this video-on-demand, find out why a patient-centered approach requires both a shift—a mind shift—and a pragmatic, coordinated approach to seeing it through. Science 37 CEO, David Coman, and VP of Internal Medicine, Dr. Debra Weinstein, join a group of leaders from Bayer, Janssen, and Novartis, to discuss what the ideal patient model really is—and how to deliver this patient-first approach.

Webinar

The Direct-to-Patient Site in Action: How to Operationalize a Virtual Site for Infectious Disease

In this 30-minute video-on-demand, a panel of experts discuss how to safely, compliantly, and efficiently operationalize a virtual site. They also cover how virtual sites (such as the Science 37 Direct-to-Patient Site), help address many challenges in infectious disease research and explore case studies that show how sponsors and CROs leverage virtual trials to improve access, equity, and ultimately accelerate recruitment and enrollment.

Webinar

The Direct-to-Patient Site in Action: How to Operationalize a Virtual Site for Dermatology

In this video-on-demand, join a panel of experts and learn first-hand how to safely, compliantly, and efficiently operationalize a virtual site. Discover how virtual sites (such as the Science 37 Direct-to-Patient Site), help address many challenges in dermatologic research. Explore case studies that show how sponsors and CROs leverage decentralized clinical trials to improve access, equity, and ultimately accelerate recruitment and enrollment.

Webinar

Disrupting the Clinical Trial: When to Decentralize?

Learn more about agile technologies and industry standards that are needed to drive clinical trial innovation, as we move towards universal adoption of decentralization.

Webinar

Virtual Sites - Are They the Future of RWE?

The adoption of virtual sites, that are powered by decentralized clinical trial tools, has increased exponentially in recent years. In this video-on-demand, industry leaders discuss how virtual sites can be implemented to improve real-world data access and long-term follow-up, as well as elaborate on the value virtual sites deliver to patients, sponsors, and CROs alike. Learn how virtual site elements are incorporated today, and how the landscape will change in the years to come.

Webinar

Let's Plan, Do, Check, and Act: Leading Diversity in Clinical Trials Through Effective Metrics

The Equity intention of the FDA is clear, the pharmaceutical industry must provide a Diversity Action Plan for all submissions—making trials more inclusive. This must be done through an evidence-based approach, providing a rationale for efficacy and safety to underrepresented populations, describing how the trials address inclusion, establishing goals for enrollment, operational tactics for enrollment and retention, and continuous monitoring to improve plans.

Webinar

Decentralization in Action: What Oncology Trials Look Like Now

What current clinical research looks like with oncology trials

Webinar

What Clinical Trial Participants Want — And How Sponsors can Deliver

Science 37 carefully examines all clinical trial options and elements needed for research — helping sponsors craft the best model to deliver clinical trial value. From cost and time savings to improved diversity, risk reduction and more, the featured speakers will evaluate the importance of decentralized clinical trials (DCTs).

Webinar

Webinar—How Decentralized Clinical Trials are Impacting Research

Learn more about agile technologies and industry standards that are needed to drive clinical trial innovation, as we move towards universal adoption of decentralization.

Webinar

Increasing Participation of Women in Oncology Clinical Trials

There are low numbers of women in oncology clinical trials. Why aren’t more women represented?

Webinar

Oncology Clinical Trials: How Hybrid Approaches are Changing The Clinical Landscape

Is your oncology clinical trial prepared for the next generation of trial methodologies?

Webinar

New Data on the Future of CNS Clinical Trials

Which decentralized components have been, and will be, most important in CNS clinical trials? What are the perceived benefits and challenges of using DCT approaches to execute CNS trials? Find out at our upcoming webinar event

Webinar

The Agile Trial: A New Clinical Leadership

Interested in reading more about how agile and decentralized approaches actually offer sponsors more centralized command and […]

Webinars

10 Things You Didn't Know About a Virtual Site

The Direct-to-Patient Site in Action: Unleash the Power of a Virtual Site

Navigating the FDA's Draft Guidance on DCTs—A Roadmap for Trial Sponsors

The Clinical Trial Shift: Sites that Follow the Patient

The Direct-to-Patient Site in Action: How to Operationalize a Virtual Site for Infectious Disease

The Direct-to-Patient Site in Action: How to Operationalize a Virtual Site for Dermatology

Disrupting the Clinical Trial: When to Decentralize?

Virtual Sites - Are They the Future of RWE?

Let's Plan, Do, Check, and Act: Leading Diversity in Clinical Trials Through Effective Metrics

Decentralization in Action: What Oncology Trials Look Like Now

What Clinical Trial Participants Want — And How Sponsors can Deliver

Webinar—How Decentralized Clinical Trials are Impacting Research

Increasing Participation of Women in Oncology Clinical Trials

Oncology Clinical Trials: How Hybrid Approaches are Changing The Clinical Landscape

New Data on the Future of CNS Clinical Trials

The Agile Trial: A New Clinical Leadership